These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10898545)

  • 21. Protection of CCRF-CEM human lymphoid cells from antifolates by retroviral gene transfer of variants of murine dihydrofolate reductase.
    Mareya SM; Sorrentino BP; Blakley RL
    Cancer Gene Ther; 1998; 5(4):225-35. PubMed ID: 9694074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of dihydrofolate reductase in human breast cancer cells and in mutant hamster cells transfected with a human dihydrofolate reductase minigene.
    Cowan KH; Goldsmith ME; Ricciardone MD; Levine R; Rubalcaba E; Jolivet J
    Mol Pharmacol; 1986 Jul; 30(1):69-76. PubMed ID: 3724746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells.
    Chen G; Wright JE; Rosowsky A
    Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Primary study on establishment of namalwa 12/MTX resistant cell strain and its mechanism].
    Chen J; Gu LJ; Ying DM; Shen M; Wu HJ
    Ai Zheng; 2002 Dec; 21(12):1335-40. PubMed ID: 12520743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of drug resistance in CCRF-CEM human leukemia cells selected by intermittent methotrexate exposure.
    McGuire JJ; Haile WH; Russell CA; Galvin JM; Shane B
    Oncol Res; 1995; 7(10-11):535-43. PubMed ID: 8866666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased folylpolyglutamate synthetase activity as a mechanism of methotrexate resistance in CCRF-CEM human leukemia sublines.
    McCloskey DE; McGuire JJ; Russell CA; Rowan BG; Bertino JR; Pizzorno G; Mini E
    J Biol Chem; 1991 Apr; 266(10):6181-7. PubMed ID: 2007575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of amino acids required for the functional up-regulation of human dihydrofolate reductase protein in response to antifolate Treatment.
    Skacel N; Menon LG; Mishra PJ; Peters R; Banerjee D; Bertino JR; Abali EE
    J Biol Chem; 2005 Jun; 280(24):22721-31. PubMed ID: 15817466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells.
    Morales C; García MJ; Ribas M; Miró R; Muñoz M; Caldas C; Peinado MA
    Mol Cancer Ther; 2009 Feb; 8(2):424-32. PubMed ID: 19190117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dihydrofolate reductase gene expression characterized by the PCR assay in human leukemia cells.
    Miyachi H; Han H; Scanlon KJ
    In Vivo; 1991; 5(1):7-12. PubMed ID: 1932630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mechanisms of development of resistance to methotrexate in choriocarcinoma cells].
    Sakai K
    Hokkaido Igaku Zasshi; 1986 Sep; 61(5):649-61. PubMed ID: 3781466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective overproduction of human dihydrofolate reductase in a methotrexate-resistant human-mouse somatic cell hybrid.
    Sastry KJ; Chan TS; Rodriguez LV
    Biochem Biophys Res Commun; 1985 Oct; 132(2):795-803. PubMed ID: 4062946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma.
    Scionti I; Michelacci F; Pasello M; Hattinger CM; Alberghini M; Manara MC; Bacci G; Ferrari S; Scotlandi K; Picci P; Serra M
    Ann Oncol; 2008 Aug; 19(8):1500-1508. PubMed ID: 18385200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells.
    Serra M; Reverter-Branchat G; Maurici D; Benini S; Shen JN; Chano T; Hattinger CM; Manara MC; Pasello M; Scotlandi K; Picci P
    Ann Oncol; 2004 Jan; 15(1):151-60. PubMed ID: 14679136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of drug-exposure conditions on the development of resistance to methotrexate or ZD1694 in cultured human leukaemia cells.
    Takemura Y; Kobayashi H; Gibson W; Kimbell R; Miyachi H; Jackman AL
    Int J Cancer; 1996 Mar; 66(1):29-36. PubMed ID: 8608962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of tumorigenicity in a methotrexate-resistant human leukemia cell line.
    Hill AB; Trent JM; Thompson FH; Danks MK; Beck WT
    Cancer Genet Cytogenet; 1993 Oct; 70(1):48-55. PubMed ID: 8221612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemistry of dihydrofolate reductase in methotrexate-sensitive and -resistant human cell lines by flow cytometry: a comparison with the cytochemical tetrazolium salt method.
    Nano R; Gerzeli G; Morandi C; Arisi C
    Acta Histochem; 1992; 93(1):290-7. PubMed ID: 1529671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methotrexate exacerbates tumor progression in a murine model of chronic myeloid leukemia.
    Sweeney CL; Diers MD; Frandsen JL; Gunther R; Verfaillie CM; McIvor RS
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1075-84. PubMed ID: 11861818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical and growth inhibition studies of methotrexate and aminopterin analogues containing a tetrazole ring in place of the gamma-carboxyl group.
    McGuire JJ; Russell CA; Bolanowska WE; Freitag CM; Jones CS; Kalman TI
    Cancer Res; 1990 Mar; 50(6):1726-31. PubMed ID: 2306727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the propensity for gene amplification between near-tetraploid and near-diploid V79 clones resistant to 150 nM methotrexate.
    Hashimoto MW; Nikaido O; Kobayashi N; Chang CC; Trosko JE; Mori T
    Carcinogenesis; 1996 Mar; 17(3):389-94. PubMed ID: 8631121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dihydrofolate Reductase and Thymidylate Synthase Transgenes Resistant to Methotrexate Interact to Permit Novel Transgene Regulation.
    Rushworth D; Mathews A; Alpert A; Cooper LJ
    J Biol Chem; 2015 Sep; 290(38):22970-6. PubMed ID: 26242737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.